Mesa Laboratories
MLAB
S$120.67
Share price
-3.87%
Change (1 day)
0.71%
Change (1 year)
Categories
Mesa Laboratories (MLAB) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : S$0.34 Billion
According to Mesa Laboratories's latest financial reports the company's total liabilities are S$0.34 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Mesa Laboratories - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-03-31 | S$0.40 B | 13.82% |
| 2023-03-31 | S$0.35 B | -15.96% |
| 2022-03-31 | S$0.42 B | 61.71% |
| 2021-03-31 | S$0.26 B | -2.31% |
| 2020-03-31 | S$0.26 B | 336.72% |
| 2019-03-31 | S$61.55 M | -27.48% |
| 2018-03-31 | S$84.88 M | -17.76% |
| 2017-03-31 | S$0.10 B | 0.64% |
| 2016-03-31 | S$0.10 B | 70.36% |
| 2015-03-31 | S$60.2 M | 44.12% |
| 2014-03-31 | S$41.77 M | 155.66% |
| 2013-03-31 | S$16.33 M | 91.74% |
| 2012-03-31 | S$8.52 M | -53.58% |
| 2011-03-31 | S$18.35 M | 437.95% |
| 2010-03-31 | S$3.41 M | 11.65% |
| 2009-03-31 | S$3.05 M | 23.52% |
| 2008-03-31 | S$2.47 M | -0% |
| 2007-03-31 | S$2.47 M | -0.69% |
| 2006-03-31 | S$2.49 M | 23.45% |
| 2005-03-31 | S$2.01 M | 42.79% |
| 2004-03-31 | S$1.41 M | 18.93% |
| 2003-03-31 | S$1.18 M | 18.67% |
| 2002-03-31 | S$1 M | -37.73% |
| 2001-03-31 | S$1.6 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | S$63.04 B | 18,018.00% | 🇺🇸 USA |
 Ametek AME | S$6.24 B | 1,694.09% | 🇺🇸 USA |
 Bruker BRKR | S$5.19 B | 1,392.37% | 🇺🇸 USA |
 3M MMM | S$45.07 B | 12,852.71% | 🇺🇸 USA |
 Steris STE | S$4.49 B | 1,190.98% | 🇮🇪 Ireland |
 AngioDynamics ANGO | S$0.12 B | -63.61% | 🇺🇸 USA |
 Danaher DHR | S$35.95 B | 10,231.68% | 🇺🇸 USA |
 Rockwell Medical
RMTI | S$28.54 M | -91.80% | 🇺🇸 USA |
 General Electric GE | S$133.14 B | 38,162.56% | 🇺🇸 USA |